Overtreating or underdiagnosing invasive pulmonary aspergillosis (IPA) in critically ill H1N1 patients: Who is right?

Intensive Care Medicine

Volumn 38, Issue 11, 2012, Pages 1733-1735

  Martin Loeches, Ignacio ^a   Valles, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID;

CD4+ T LYMPHOCYTE; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DRUG EFFICACY; EDITORIAL; HEMATOPOIETIC STEM CELL; HUMAN; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG ASPERGILLOSIS; MIXED INFECTION; NEUTROPENIA; ORGAN TRANSPLANTATION; VIRUS LOAD;

ANTIFUNGAL AGENTS; DIAGNOSTIC ERRORS; GLUCOCORTICOIDS; HUMANS; INAPPROPRIATE PRESCRIBING; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INVASIVE PULMONARY ASPERGILLOSIS; SUPERINFECTION;

EID: 84868211773     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2677-y     Document Type: Editorial

References (13)

1. Simonsen L (1999) The global impact of influenza on morbidity and mortality. Vaccine 17(Suppl 1):S3-S10
2. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL, Klimov A, Lindstrom SE, Balish A, Medina MJ, Wallis TR, Guarner J, Paddock CD, Shieh WJ, Zaki SR, Sejvar JJ, Shay DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM, Influenza Special Investigations Team (2005) Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 353:2559-2567
3. Martín-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, Albaya A, Cerdá E, Catalán RM, Luque P, Paredes A, Navarrete I, Rello J, Rodríguez A, H1N1 SEMICYUC Working Group (2011) Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A (H1N1) virus. Chest 139:555-562
4. Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR 3rd, Higgs E, Randolph AG, Smoot BE, Thompson BT, NHLBIARDS Network (2012) Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 40:1487-1498
5. Viasus D, Paño-Pardo JR, Pachón J, Campins A, López-Medrano F, Villoslada A, Fariñas MC, Moreno A, Rodríguez-Baño J, Oteo JA, Martínez-Montauti J, Torre-Cisneros J, Segura F, Gudiol F, Carratalà J, Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI) (2011) Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 17:738-746
6. Brundage JF (2006) Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 6:303-312
7. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, Lagrou K, Wilmer A, Jorens P, Hermans G (2012) Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1-patients: a retrospective study. Intensive Care Med. doi: 10.1007/s00134-012-2673-2
8. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821
9. Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, Vandewoude K, Vogelaers D, The AspICU Study Investigators (2012) A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186:56-64
10. Thompson GR 3rd, Patterson TF (2011) Pulmonary aspergillosis: recent advances. Semin Respir Crit Care Med 32:673-681
11. Alimonti JB, Ball TB, Fowke KR (2003) Mechanisms of CD4 ? T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 84:1649-1661
12. Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, Banner D, Ng DC, Socias L, Loza A, Andaluz D, Maravi E, Gómez-Sánchez MJ, Gordón M, Gallegos MC, Fernandez V, Aldunate S, León C, Merino P, Blanco J, Martin-Sanchez F, Rico L, Varillas D, Iglesias V, Marcos MÁ, Gandía F, Bobillo F, Nogueira B, Rojo S, Resino S, Castro C, Ortiz de Lejarazu R, Kelvin D (2010) Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 14:R167
13. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y, Korean Society of Critical Care Medicine H1N1 Collaborative (2011) Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 183:1207-1214